Evidence map›Paper›PMID 27751868›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2016

Microfluidic platform for electrophysiological recordings from host-stage hookworm and Ascaris suum larvae: A new tool for anthelmintic research.

Janis C Weeks, William M Roberts, Kristin J Robinson, Melissa Keaney, Jon J Vermeire, Joseph F Urban, Shawn R Lockery, John M Hawdon

Open access · goldAbstract readValidation Study
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  7. Pharmaceuticals (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Anthelmintics - From Discovery to Resistance III (Indian Rocks Beach, FL, 2018).International journal for parasitology. Drugs and drug resistance · 2018
    Article
  12. Article
  13. Article
  14. Anthelmintics: From discovery to resistance II (San Diego, 2016).International journal for parasitology. Drugs and drug resistance · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Janis C WeeksInstitute of Neuroscience and African Studies Program, University of Oregon, 1254 University of Oregon, Eugene, OR 97403-1254, USA. Electronic address: jweeks@uoregon.edu.
William M RobertsInstitute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403-1254, USA. Electronic address: billr@uoregon.edu.
Kristin J RobinsonInstitute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403-1254, USA. Electronic address: kristinr@uoneuro.uoregon.edu.
Melissa KeaneyDepartment of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC 20037, USA. Electronic address: keaney.melissa@gmail.com.
Jon J VermeireCenter for Discovery and Innovation in Parasitic Diseases, Dept. of Pathology and Laboratory Medicine, UC, San Francisco, USA. Electronic address: jon.vermeire@gmail.com.
Joseph F UrbanUS Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomic and Immunology Laboratory, Beltsville, MD, USA. Electronic address: joe.urban@ars.usda.gov.
Shawn R LockeryInstitute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403-1254, USA. Electronic address: shawn@uoregon.edu.
John M HawdonDepartment of Microbiology, Immunology, and Tropical Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC 20037, USA. Electronic address: jhawdon@email.gwu.edu.
University of Oregon · USGeorge Washington University · USAgricultural Research Service · USUniversity of California, San Francisco · US

Funding

Determining the molecular mechanism of anthelmintic resistance in hookwormsR21AI115012 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI HAWDON, JOHN M · 2015 to 2016
$435k
Developing tools for genetic manipulation of hookwormsR21AI101369 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI HAWDON, JOHN M · 2013 to 2014
$407k
NIAID NIH HHS R21 AI101369NIAID NIH HHS R21 AI115012
6 · The paper itself

Abstract

The screening of candidate compounds and natural products for anthelmintic activity is important for discovering new drugs against human and animal parasites. We previously validated in Caenorhabditis elegans a microfluidic device ('chip') that records non-invasively the tiny electrophysiological signals generated by rhythmic contraction (pumping) of the worm's pharynx. These electropharyngeograms (EPGs) are recorded simultaneously from multiple worms per chip, providing a medium-throughput readout of muscular and neural activity that is especially useful for compounds targeting neurotransmitter receptors and ion channels. Microfluidic technologies have transformed C. elegans research and the goal of the current study was to validate hookworm and Ascaris suum host-stage larvae in the microfluidic EPG platform. Ancylostoma ceylanicum and A. caninum infective L3s (iL3s) that had been activated in vitro generally produced erratic EPG activity under the conditions tested. In contrast, A. ceylanicum L4s recovered from hamsters exhibited robust, sustained EPG activity, consisting of three waveforms: (1) conventional pumps as seen in other nematodes; (2) rapid voltage deflections, associated with irregular contractions of the esophagus and openings of the esophogeal-intestinal valve (termed a 'flutter'); and (3) hybrid waveforms, which we classified as pumps. For data analysis, pumps and flutters were combined and termed EPG 'events.' EPG waveform identification and analysis were performed semi-automatically using custom-designed software. The neuromodulator serotonin (5-hydroxytryptamine; 5HT) increased EPG event frequency in A. ceylanicum L4s at an optimal concentration of 0.5 mM. The anthelmintic drug ivermectin (IVM) inhibited EPG activity in a concentration-dependent manner. EPGs from A. suum L3s recovered from pig lungs exhibited robust pharyngeal pumping in 1 mM 5HT, which was inhibited by IVM. These experiments validate the use of A. ceylanicum L4s and A. suum L3s with the microfluidic EPG platform, providing a new tool for screening anthelmintic candidates or investigating parasitic nematode feeding behavior.

Indexed as

AncylostomaAnimalsAnthelminticsAscaris suumDrug Evaluation, PreclinicalElectrophysiological PhenomenaLarvaMicrofluidicsParasitologyAnthelminticsAncylostomaAnthelminticAscarisElectropharyngeogramElectrophysiologyHookwormIvermectinMicrofluidicScreenChipSerotonin

Identifiers

PMID27751868
PMCPMC5196495
OpenAlexW2519229948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.